RET and thyroid gland carcinoma: To this aim, RET positive (TT and MZ-CRC-1) and negative (8505C) thyroid cancer cell lines and TRKA positive (KM12) and negative (HCT-116) CRC cell lines were injected in immunocompromised mice.